Request Discount

3D Printed Drugs Market (Technology - Inkjet Printing, Fused Deposition Modelling (FDM), Stereolithography (SLA), and Others; Application - Orthopedic, Hearing & Audibility Aid, Medical Implants, Dental, Neurology, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027

  • Published : August, 2021

  • Rep Id : HC08711

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on 3D printed drugs market provides in-depth analysis of segments and sub-segments in the global as well as regional 3D printed drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional 3D printed drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global 3D printed drugs market. According to the report, the global 3D printed drugs market is projected to grow at a CAGR of 7.82% over the forecast period of 2021-2027.

 

Market Insight

The 3D printed drugs market was valued at USD 274 million in 2020 and is expected to reach USD 458.5249 million in 2027, with a CAGR of 7.82% during the forecast period. 3D printing has become one of the most pioneering technologies in the pharmaceutical field. There has been a significant development in the manufacture of drug delivery and medical devices within the last decade. 3D printing facilitates the potential for printing dosage forms on-demand, with low cost and ease of use. The industry is leading towards personalized medicine because the dosing and release characteristics of the drug delivery devices can be easily changed. It can be done by altering the geometries of the 3D design using computer-aided design (CAD). The approval by FDA for the 3D-printed drugs has fueled interest in 3D printing technology in the pharmaceutical industry.

 

The rise in the rate of adoption of personalized drugs is the key driving factor for the 3D printed drugs market. The need for personalized dosing arises from differentiation in the patient’s age, weight, and severity of the disease. The personalized drugs are suited for the patient’s individual needs thus minimizing the potential for adverse effects of the drug. Individualized medications fabricated through 3D printed offer an important benefit to patients. Printable dosage forms on paper are easier to deliver to the patient than powder-based printed forms. Furthermore, the proliferating prevalence of chronic diseases is also driving the global 3D printed drugs market. The investments in research and development of 3D printed drugs and innovation in the manufacturing of biologics are anticipated to yield more products during the forecast period. The investments in research and development of 3D printed drugs and innovation are anticipated to yield more products during the forecast period. With the outbreak of the COVID-19 pandemic, urgent needs for medical and specialized products have been overwhelming especially personal protective equipment. The conventional production line of medical devices has been challenged by excessive global demand during the pandemic. The need for an easy, low-cost, and rapid fabrication method is felt more than ever in recent times. The manufacturers referred to 3D printing to fill the gap in a scramble to address this shortfall and boost the production line of medical devices.

 

Geographically, North America holds a large share in the global 3D printed drugs market owing to the increasing number of chronic disorders, presence of advanced domestic healthcare infrastructure in this region. The factors such as high investment in research and development, and rising adoption of technological advancements in 3D printing are also driving the North America 3D printed drugs market. The presence of a large geriatric population in countries such as Germany and The United Kingdom drives the growth of the European 3D printed drugs market.

 

Segment Covered

The report on the global 3D printed drugs market covers segments such as technology, and application. On the basis of technology, the sub-markets include inkjet printing, fused deposition modelling (FDM), stereolithography (SLA), and others. On the basis of application, the sub-markets include orthopedic, hearing & audibility aid, medical implants, dental, neurology, and others.


 

3D Printed Drugs Market


Companies Profiled:

The report provides profiles of the companies in the market such as GlaxoSmithKline plc., Hewlett Packard Caribe, Aprecia Pharmaceuticals, 3D Printer Drug Machine, FabRx Ltd., Cycle Pharmaceuticals, and Other Companies.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the 3D printed drugs market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount